Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 45,376 | 47,198 | 62,519 | 50,214 | 47,387 |
| Cost of Goods | 9,769 | 9,791 | 12,118 | 10,508 | 9,635 |
| Gross Profit | 35,607 | 37,407 | 50,401 | 39,706 | 37,752 |
| Operating Expenses | 51,334 | 55,365 | 56,441 | 55,890 | 55,361 |
| Operating Income | -14,958 | -17,167 | -5,922 | -15,676 | -16,974 |
| Interest Expense | 1,562 | 1,570 | 1,350 | 1,338 | 1,321 |
| Other Income | 647 | 776 | -2,122 | 726 | 897 |
| Pre-tax Income | -15,873 | -17,961 | -9,394 | -16,288 | -17,398 |
| Net Income Continuous | -15,873 | -17,961 | -9,394 | -16,288 | -17,398 |
| Net Income | $-15,873 | $-17,961 | $-9,394 | $-16,288 | $-17,398 |
| EPS Basic Total Ops | -0.24 | -0.28 | -0.14 | -0.26 | -0.28 |
| EPS Basic Continuous Ops | -0.24 | -0.28 | -0.15 | -0.26 | -0.28 |
| EPS Diluted Total Ops | -0.24 | -0.28 | -0.14 | -0.26 | -0.28 |
| EPS Diluted Continuous Ops | -0.24 | -0.28 | -0.15 | -0.26 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.28 | -0.12 | -0.26 | -0.28 |
| EBITDA(a) | $-12,821 | $-16,001 | $-3,049 | $-12,828 | $-14,361 |